BUSINESS● LOWSep 30 · Sep 30, 2026, 10:59 AM
Vanda posts late-stage trial win for HETLIOZ in DSWPD, setting up another label expansion
Seeking Alpha Tech · global
Vanda has achieved a late-stage trial victory for its drug HETLIOZ in treating DSWPD, which positions the company for further label expansion. This indicates progress in pharmaceutical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowHow Ivory Coast's national lottery resists online competitionJeune AfriqueBUSINESS27m agoChinese carmakers gear up European production to sidestep tariffs, import quotaSouth China Morning Post